Early and late stage gene therapy interventions for inherited retinal degenerations

C Botto, M Rucli, MD Tekinsoy, J Pulman… - Progress in Retinal and …, 2022 - Elsevier
Inherited and age-related retinal degeneration is the hallmark of a large group of
heterogeneous diseases and is the main cause of untreatable blindness today. Genetic …

[HTML][HTML] Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives

AV Garafalo, AV Cideciyan, E Héon, R Sheplock… - Progress in retinal and …, 2020 - Elsevier
Due to improved phenotyping and genetic characterization, the field of 'incurable'and
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …

Genetic and clinical findings in a large cohort of Chinese patients with suspected retinitis pigmentosa

FJ Gao, JK Li, H Chen, FY Hu, SH Zhang, YH Qi, P Xu… - Ophthalmology, 2019 - Elsevier
Purpose To characterize the genetic landscape of patients with suspected retinitis
pigmentosa (RP) in the Chinese population. Design Cohort study. Participants A total of …

Reserpine maintains photoreceptor survival in retinal ciliopathy by resolving proteostasis imbalance and ciliogenesis defects

HY Chen, M Swaroop, S Papal, AK Mondal, HB Song… - elife, 2023 - elifesciences.org
Ciliopathies manifest from sensory abnormalities to syndromic disorders with multi-organ
pathologies, with retinal degeneration a highly penetrant phenotype. Photoreceptor cell …

Mouse models of inherited retinal degeneration with photoreceptor cell loss

GB Collin, N Gogna, B Chang, N Damkham, J Pinkney… - Cells, 2020 - mdpi.com
Inherited retinal degeneration (RD) leads to the impairment or loss of vision in millions of
individuals worldwide, most frequently due to the loss of photoreceptor (PR) cells. Animal …

[HTML][HTML] Advancing clinical trials for inherited retinal diseases: recommendations from the Second Monaciano Symposium

DA Thompson, A Iannaccone, RR Ali… - … vision science & …, 2020 - arvojournals.org
Major advances in the study of inherited retinal diseases (IRDs) have placed efforts to
develop treatments for these blinding conditions at the forefront of the emerging field of …

Genome editing, a superior therapy for inherited retinal diseases

AL Yan, SW Du, K Palczewski - Vision research, 2023 - Elsevier
Gene augmentation and genome editing are promising strategies for the treatment of
monogenic inherited retinal diseases. Although gene augmentation treatments are …

Genome-editing strategies for treating human retinal degenerations

J Quinn, A Musa, A Kantor, ME McClements… - Human Gene …, 2021 - liebertpub.com
Inherited retinal degenerations (IRDs) are a leading cause of blindness. Although gene-
supplementation therapies have been developed, they are only available for a small …

RNA therapeutics in ophthalmology-translation to clinical trials

A Gupta, KN Kafetzis, AD Tagalakis… - Experimental eye …, 2021 - Elsevier
The use of RNA interference technology has proven to inhibit the expression of many target
genes involved in the underlying pathogenesis of several diseases affecting various …

Expanding the phenotype of THRB: a range of macular dystrophies as the major clinical manifestations in patients with a dominant splicing variant

E Fernández-Suárez, M González-del Pozo… - Frontiers in Cell and …, 2023 - frontiersin.org
Inherited retinal dystrophies (IRDs) are a clinically and genetically heterogeneous group of
disorders that often severely impair vision. Some patients manifest poor central vision as the …